Contraceptive Technology Update
RSSArticles
-
Food and Drug Administration takes steps to ensure safety of Essure
The Food and Drug Administration has taken steps to ensure the safety of the Essure method of permanent birth control. The agency has issued a new, mandatory clinical study to determine heightened risks for particular women.
-
2 studies show monthly vaginal ring protects women against HIV
Results presented at the 2016 Conference on Retroviruses and Opportunistic Infections from two large Phase III clinical trials suggest that a monthly vaginal ring containing the antiretroviral drug dapivirine (and no contraceptives) can safely help prevent HIV-1 infection in women.
-
Update on emergency contraception: What family planning providers need to know
Are you up to speed on emergency contraception? The Association of Reproductive Health Professionals has just released a two-part webinar to help providers review evidence-based information on all things EC, from its efficacy to the state of access in the United States.
-
Emphasize importance of HPV vaccine for prevention of cancer
Sixty-nine of the top cancer centers in the United States have joined to emphasize the importance of human papillomavirus vaccination for the prevention of cancer. Despite the availability of three HPV vaccines, vaccination rates lag far behind those of other routine adolescent vaccines.
-
Contraceptive selection for women with epilepsy
Epilepsy is common, affecting 2.2 million Americans, of which approximately half are women of reproductive age.1 The Association of Reproductive Health Professionals has just released a webinar, “Women with Nerve: Providing Reproductive Health Care for Women with Epilepsy,” to help providers review evidence-based information on the subject.
-
U.S. Preventive Services Task Force issues new breast cancer screening guidance
The U.S. Preventive Services Task Force has issued new guidance on breast cancer screening and called for mammography every two years for women ages 50-74. For women ages 40-49, the Task Force recommends informed, individualized decision-making based on a woman’s values, preferences, and health history.
-
Zika infections: Obtain perspective on impact of virus and how to offer effective contraception to women
Zika infections are viral infections spread from an infected person by a mosquito called the Aedes aegypti mosquito. For the Zika infection to gain a foothold in an area of the world, it must be an area that sustains Aedes aegypti mosquitoes, which is the case for all countries in our hemisphere, except for Canada, which is too cold, and Chile, which is too cold and too dry.
-
Sexual transmission of Zika virus possible: Will it impact virus spread?
News of the rapid spread of the Zika virus through 18 Latin American countries and the Caribbean has captured headlines. The World Health Organization predicts that the virus could affect more than 4 million people in the Americas in 2016 alone.
-
Azithromycin remains effective in treatment of urogenital chlamydia, study data suggest
Results of a new study, conducted by researchers at the University of Alabama at Birmingham, the Los Angeles-based University of Southern California, and the Los Angeles County Department of Health Services, confirm that azithromycin remains effective in the treatment of urogenital chlamydia.1
-
Snapshot from National HIV Prevention Conference: Strides have been made, yet hurdles remain
The December 2015 National HIV Prevention Conference saw exciting developments announced by the CDC and partners, including new data on trends and disparities in the U.S. HIV epidemic.